Treier, A.-K. http://orcid.org/0000-0002-2520-6801
Döpfner, M.
Ravens-Sieberer, U.
Görtz-Dorten, A.
Boecker, M.
Goldbeck, C.
Banaschewski, T.
Aggensteiner, P.-M.
Hanisch, C.
Ritschel, A.
Kölch, M.
Daunke, A.
Roessner, V.
Kohls, G.
Kaman, A.
Aggensteiner, Pascal-Maurice
Banaschewski, Tobias
Bernheim, Dorothee
Bienioschek, Stefanie
Boecker, Maren
Brandeis, Daniel
Daunke, Andrea
Döpfner, Manfred
Fegert, Jörg M.
Frenk, Franziska
Giller, Franziska
Ginsberg, Claudia
Goldbeck, Carolina
Görtz-Dorten, Anja
Groh, Monja
Hanisch, Charlotte
Hellmich, Martin
Hohmann, Sarah
Holz, Nathalie
Igel, Christine
Junghänel, Michaela
Kaiser, Anna
Kaman, Anne
Katmer-Amet, Betül
Katzmann, Josepha
Kölch, Michael
Millenet, Sabina
Mücke, Kristina
Ravens-Sieberer, Ulrike
Ritschel, Anne
Roessner, Veit
Schreiner, Anne
Schroth, Jennifer
Schüller, Anne
Steiner, Marie-Therese
Steiner, Marion
Treier, Anne-Katrin
Uhlmann, Anne
Winkler, Matthias
Zaplana, Sara
,
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01GL1741B, 01GL1741D)
Universitätsklinikum Köln
Article History
Received: 16 May 2022
Accepted: 9 February 2023
First Online: 17 February 2023
Declarations
:
: MD receives royalties from publishing companies as an author of books and treatment manuals on child behavioral therapy and of assessment manuals published by Beltz, Elsevier, Enke, Guilford, Hogrefe, Huber, Kohlhammer, Schattauer, Springer, and Wiley. He receives income as a consultant for Child Behavior Therapy at the National Association of Statutory Health Insurance Physicians. He also receives consulting income and research support from Lilly, Medice, Takeda, and eyelevel GmbH. AGD receives royalties from publishing companies as an author of books and treatment manuals on child behavioral therapy and assessment manuals, including the treatment manuals evaluated in this trial. She receives income as a consultant for Child Behavior Therapy at the National Association of Statutory Health Insurance Physicians. She also receives consulting income and research support from Medice and eyelevel GmbH. TB served in an advisory or consultancy role for ADHS digital, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or speaker’s fees from Medice and Takeda. He received royalties from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. CH receives royalties from a publishing company as the author of a treatment manual. MK receives royalties from publishing companies as an author of books. He served as PI or CI in clinical trials of Lundbeck, Pascoe, and Janssen-Cilag. He received grants from the BMBF, BMFSFJ, BZgA and Bundeswehr. He served as a scientific advisor for Janssen. The present work is unrelated to the above grants and relationships. VR has received lecture honoraria from Infectopharm and Medice companies. He has carried out clinical trials in cooperation with Servier and Shire Pharmaceuticals/Takeda companies. The present work is unrelated to the above grants and relationships. All other authors declare no conflict of interest.
: Ethical approval has been obtained for all study centers.
: Verbal and written consent was obtained for children and parents.